Tag: IN.PACT AV Access

trerotola misra tan av access dcbs drug coated balloons

More mixed results for DCBs in AV access maintenance as evidence...

Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Medtronic IN.PACT AV

Two-year IN.PACT AV Access results presented at CX 2021

Medtronic recently announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually...

LINC 2021 first time data releases in arteriovenous access: Positive results...

New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) are positive for the IN.PACT AV drug-coated...
Medtronic IN.PACT AV

Six-month IN.PACT AV Access results show superiority of DCB angioplasty

Just-published six-month results of the IN.PACT AV Access study show that drug-coated balloon (DCB) angioplasty is superior to standard angioplasty for the treatment of...

LINC 2020: Positive new data for AV access interventions released

New arteriovenous (AV) access results were presented at the 2020 Leipzig Interventional Course (LINC; 28–31 January, Leipzig, Germany), including data on percutaneous AV fistula...

Medtronic DCB receives US FDA approval to treat arteriovenous fistula lesions

Medtronic today announced US Food and Drug Administration (FDA) approval of the IN.PACT AV drug-coated balloon (DCB), a paclitaxel-coated balloon indicated for the treatment...